Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00182637
Status:
COMPLETED
Last Update Posted:
2020-08-03
First Post:
2005-09-15
Brief Title:
Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Sponsor:
Organization:
Jonsson Comprehensive Cancer Center